academic article

• Potential impact of the COVID-19 pandemic on everyday preferences for persons with cognitive impairment..  International psychogeriatrics.  36:1256-1261. 2023
• Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment..  Frontiers in neurology.  -. 2023
• Projection of Care Partners' Preferences in the Proxy Assessments of Everyday Preferences for Persons With Cognitive Impairment..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  31:254-263. 2022
• Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid..  Brain pathology (Zurich, Switzerland).  32:-. 2021
• Longitudinal Changes in Neuropsychiatric Symptoms: Impact of Discrepancy in Everyday Preferences Between Persons With Cognitive Impairment and Their Care Partners..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:619-623. 2021
• Longitudinal differences in everyday preferences: Comparisons between people with cognitive impairment and their care partners..  International journal of geriatric psychiatry.  37. 2021
• The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography..  Science translational medicine.  13. 2021
• Predictors of the importance of everyday preferences for older adults with cognitive impairment..  International psychogeriatrics.  34:287-294. 2021
• Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease..  JAMA neurology.  74:427-436. 2017
• Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly..  Neurology.  87:920-6. 2016
• Tau positron emission tomographic imaging in aging and early Alzheimer disease..  Annals of neurology.  79:110-9. 2015
• Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques..  Proceedings of the National Academy of Sciences of the United States of America.  112:15556-61. 2015
• Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue..  Annals of neurology.  78:787-800. 2015
• Mild to moderate Alzheimer dementia with insufficient neuropathological changes..  Annals of neurology.  75:597-601. 2014
• Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  22:1642-51. 2014
• Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology..  The Journal of comparative neurology.  521:4236-48. 2013
• Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease..  The Journal of neuroscience : the official journal of the Society for Neuroscience.  33:13300-11. 2013
• Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease..  Journal of neuropathology and experimental neurology.  72:462-71. 2013
• A phenotypic change but not proliferation underlies glial responses in Alzheimer disease..  The American journal of pathology.  182:2332-44. 2013
• Neuropathology of Alzheimer's disease..  Handbook of clinical neurology.  233-43. 2008
• Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease..  Journal of Alzheimer's disease : JAD.  1:119-134. 1998